Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyronaridine Artesunate vs Chloroquine in Acute Vivax Malaria
NCT00440999Phase 3Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Mar 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of artesunate + pyronaridine in Plasmodium vivax malaria (2 arms), sponsored by Medicines for Malaria Venture. Primary endpoint: Crude Cure Rate on Day 14. Started Mar 2007; status: completed.
02
Drugs
artesunate + pyronaridine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT00440999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440999.